MedTrace Logo

A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications

NCT07380412 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-02-02

No results posted yet for this study

Summary

This is a hybrid, two-arm, triple-blind, placebo-controlled, randomized clinical trial evaluating the efficacy of the Stasis supplement on reducing oxidative stress, cortisol levels, and side effects associated with stimulant medications used for ADHD over a three-month period in adults.

Conditions

  • ADHD
  • Sleep Disturbance
  • Brain Fog

Interventions

DIETARY_SUPPLEMENT

Stasis Daytime and Nighttime

Daytime taken with stimulant medication and food. Nighttime taken 30 minutes before bedtime on an empty stomach.

DIETARY_SUPPLEMENT

Placebo

Matched placebo product in taste and appearance.

Sponsors & Collaborators

  • Citruslabs

    collaborator INDUSTRY

  • Outliers, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-12
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07380412 on ClinicalTrials.gov